Abound Wealth Management’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313 Hold
7
﹤0.01% 1021
2026
Q1
$362 Sell
7
-1
-13% -$70 ﹤0.01% 1098
2025
Q4
$738 Hold
8
﹤0.01% 927
2025
Q3
$594 Hold
8
﹤0.01% 914
2025
Q2
$1.04K Hold
8
﹤0.01% 798
2025
Q1
$1.27K Hold
8
﹤0.01% 737
2024
Q4
$1.48K Hold
8
﹤0.01% 699
2024
Q3
$1.69K Buy
8
+2
+33% +$347 ﹤0.01% 728
2024
Q2
$803 Hold
6
﹤0.01% 754
2024
Q1
$1.29K Hold
6
﹤0.01% 742
2023
Q4
$1.22K Hold
6
﹤0.01% 737
2023
Q3
$1.19K Hold
6
﹤0.01% 696
2023
Q2
$1.95K Hold
6
﹤0.01% 650
2023
Q1
$1.41K Hold
6
﹤0.01% 618
2022
Q4
$1.51K Hold
6
﹤0.01% 573
2022
Q3
$1.06K Buy
+6
New +$1.21K ﹤0.01% 596

Other funds holding INSP

Abound Wealth Management's INSP Position: Q2 2026 in Review

Abound Wealth Management held its Inspire Medical Systems (INSP) position steady in Q2 2026 at 7 shares worth $313. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

Abound Wealth Management first reported a position in INSP in Q3 2022 and has held it in 16 quarters since. The position peaked at $1.95K in Q2 2023. 276 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Abound Wealth Management held 7 shares of Inspire Medical Systems worth $313 as of Q2 2026.
  • Abound Wealth Management left its Inspire Medical Systems share count unchanged in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1021 holding.
  • Abound Wealth Management first reported a position in Inspire Medical Systems in Q3 2022 and has held it in 16 quarters since.
  • Abound Wealth Management's Inspire Medical Systems position peaked at $1.95K in Q2 2023.
  • 276 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.